• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小肠神经内分泌肿瘤的外科治疗:特殊要求及其对分期和预后的影响。

Surgical Management of Small Bowel Neuroendocrine Tumors: Specific Requirements and Their Impact on Staging and Prognosis.

作者信息

Pasquer Arnaud, Walter Thomas, Hervieu Valérie, Forestier Julien, Scoazec Jean-Yves, Lombard-Bohas Catherine, Poncet Gilles

机构信息

Hospices Civils de Lyon, Hôpital Edouard Herriot, Chirurgie digestive, Lyon Cedex 03, France.

Hospices Civils de Lyon, Hôpital Edouard Herriot, Service de Gastroentérologie et d'oncologie digestive, Lyon Cedex 03, France.

出版信息

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S742-9. doi: 10.1245/s10434-015-4620-2. Epub 2015 May 27.

DOI:10.1245/s10434-015-4620-2
PMID:26014153
Abstract

BACKGROUND

Small bowel neuroendocrine tumors (SB-NETs) are characterized by two main features: they usually are metastatic at diagnosis and multiple in 30 % of cases. As such, SB-NETs require specific surgical management. This retrospective study examined local recurrence, survival, and prognosis of SB-NETs after adapted surgery.

METHODS

All consecutive patients with SB-NETs who underwent resection of at least one primary tumor between 1 January 2000 and 1 January 2013 were analyzed. The preoperative morphologic workup, histologic classification, and metastatic lymph node (LN) ratio (LNs involved/removed) were recorded.

RESULTS

The study enrolled 107 patients, 35 (33 %) of whom had multiple SB-NETs (range 1-44; mean 3.1). Preoperative imaging and perioperative surgical examination missed 61 and 33 % of SB-NETs, respectively, in contrast to pathologic examination. Of the 107 patients, 43 % had carcinoid syndrome, 70 % had metastatic disease, and 90 % had LN involvement. The median number of LNs retrieved was 12 (range 1-69). The LN ratio (LNs involved/removed) was 0.25. The highest tumoral grades were G1 (in 61 % of patients) and G2 (in 37 % of patients). Of the 107 patients, 13 (12 %) had local LN recurrence. The rate of LN recurrence-free survival at 5 years was 88 %. The median overall survival (OS) time was 128 months (range 91-165 months). In the multivariate analysis, high chromogranin A (CgA) levels and peritoneal carcinomatosis were significantly associated with shorter OS.

CONCLUSIONS

Systematic palpation of the entire small bowel detects more multiple NETs than preoperative imaging. Systematic surgery with extensive LN resection is associated with low local recurrence. High CgA levels and carcinomatosis are linked with shorter survival.

摘要

背景

小肠神经内分泌肿瘤(SB-NETs)具有两个主要特征:它们在诊断时通常已发生转移,且30%的病例为多发。因此,SB-NETs需要特定的手术治疗。这项回顾性研究探讨了适应性手术后SB-NETs的局部复发、生存及预后情况。

方法

分析了2000年1月1日至2013年1月1日期间所有连续接受至少一个原发性肿瘤切除的SB-NETs患者。记录术前形态学检查、组织学分类及转移淋巴结(LN)比例(受累淋巴结/切除淋巴结)。

结果

该研究纳入了107例患者,其中35例(33%)患有多发SB-NETs(范围为1至44个;平均3.1个)。与病理检查相比,术前影像学检查和围手术期手术检查分别漏诊了61%和33%的SB-NETs。107例患者中,43%有类癌综合征,70%有转移性疾病,90%有淋巴结受累。切除淋巴结的中位数为12个(范围为1至69个)。LN比例(受累淋巴结/切除淋巴结)为0.25。最高肿瘤分级为G1(61%的患者)和G2(37%的患者)。107例患者中,13例(12%)有局部淋巴结复发。5年无淋巴结复发生存率为88%。中位总生存(OS)时间为128个月(范围为91至165个月)。多因素分析中,高嗜铬粒蛋白A(CgA)水平和腹膜癌转移与较短的OS显著相关。

结论

对整个小肠进行系统触诊比术前影像学检查能发现更多的多发神经内分泌肿瘤。广泛切除淋巴结的系统性手术与低局部复发率相关。高CgA水平和癌转移与较短的生存期相关。

相似文献

1
Surgical Management of Small Bowel Neuroendocrine Tumors: Specific Requirements and Their Impact on Staging and Prognosis.小肠神经内分泌肿瘤的外科治疗:特殊要求及其对分期和预后的影响。
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S742-9. doi: 10.1245/s10434-015-4620-2. Epub 2015 May 27.
2
Lymph node metastases in patients undergoing surgery for a gallbladder cancer. Extension of the lymph node dissection and prognostic value of the lymph node ratio.接受胆囊癌手术患者的淋巴结转移。淋巴结清扫范围及淋巴结比率的预后价值。
Ann Surg Oncol. 2015 Mar;22(3):811-8. doi: 10.1245/s10434-014-4044-4. Epub 2014 Sep 9.
3
Prognostic Role of Lymph Node Positivity and Number of Lymph Nodes Needed for Accurately Staging Small-Bowel Neuroendocrine Tumors.淋巴结阳性和准确分期小肠神经内分泌肿瘤所需的淋巴结数量的预后作用。
JAMA Surg. 2019 Feb 1;154(2):134-140. doi: 10.1001/jamasurg.2018.3865.
4
Toward a Preoperative Classification of Lymph Node Metastases in Patients with Small Intestinal Neuroendocrine Tumors in the Era of Intestinal-Sparing Surgery.在保留肠道手术时代,小肠神经内分泌肿瘤患者术前淋巴结转移的分类研究
Neuroendocrinology. 2016;103(5):552-9. doi: 10.1159/000441423. Epub 2015 Oct 8.
5
Revisiting the concept of lymph node metastases of pancreatic head cancer: number of metastatic lymph nodes and lymph node ratio according to N stage.重新审视胰头癌淋巴结转移的概念:根据N分期的转移淋巴结数量及淋巴结比率
Ann Surg Oncol. 2014 May;21(5):1545-51. doi: 10.1245/s10434-013-3473-9. Epub 2014 Jan 14.
6
Small bowel neuroendocrine tumors: A critical analysis of diagnostic work-up and operative approach.小肠神经内分泌肿瘤:诊断检查与手术方法的批判性分析
J Surg Oncol. 2016 Nov;114(6):671-676. doi: 10.1002/jso.24390. Epub 2016 Aug 11.
7
Extent of Lymph Node Dissection for Small Bowel Neuroendocrine Tumors.小肠神经内分泌肿瘤的淋巴结清扫范围。
World J Surg. 2021 Jan;45(1):197-202. doi: 10.1007/s00268-020-05710-z. Epub 2020 Jul 31.
8
Survival and disease recurrence in patients operated for small intestinal neuroendocrine tumors at a referral hospital.在一家转诊医院接受手术治疗的小肠类癌患者的生存和疾病复发情况。
Surg Oncol. 2020 Dec;35:336-343. doi: 10.1016/j.suronc.2020.09.015. Epub 2020 Sep 18.
9
HSP90 expression and early recurrence in gastroenteropancreatic neuroendocrine tumors: Potential for a novel therapeutic target.HSP90 表达与胃肠胰神经内分泌肿瘤的早期复发:潜在的新型治疗靶点。
Surg Oncol. 2020 Dec;35:460-465. doi: 10.1016/j.suronc.2020.09.018. Epub 2020 Oct 7.
10
Surgical Principles in the Management of Small Bowel Neuroendocrine Tumors.小肠神经内分泌肿瘤的外科治疗原则。
Curr Treat Options Oncol. 2020 Aug 29;21(11):88. doi: 10.1007/s11864-020-00784-2.

引用本文的文献

1
Prognosis of NETs: Has There Been Improvement over the Last 30 Years?神经内分泌肿瘤的预后:在过去30年里有改善吗?
Neuroendocrinology. 2025 May 30:1-13. doi: 10.1159/000546613.
2
Small bowel neuroendocrine tumor with scoliosis: A case report and literature review.小肠神经内分泌肿瘤伴脊柱侧弯:一例报告及文献综述
Medicine (Baltimore). 2025 May 2;104(18):e42395. doi: 10.1097/MD.0000000000042395.
3
Outcome of Debulking the Mesenteric Mass in Symptomatic Patients with Locally Advanced Small Intestine Neuroendocrine Tumors.对有症状的局部晚期小肠神经内分泌肿瘤患者进行肠系膜肿物减瘤术的结果
Cancers (Basel). 2025 Apr 14;17(8):1318. doi: 10.3390/cancers17081318.
4
Evaluation of hand-assisted laparoscopic surgery of small intestinal neuroendocrine tumours as an alternative surgical treatment to open surgery.评估手辅助腹腔镜手术治疗小肠神经内分泌肿瘤作为开放手术的替代手术治疗方法。
Langenbecks Arch Surg. 2025 Mar 6;410(1):90. doi: 10.1007/s00423-025-03658-z.
5
Lymphatic and vascular anatomy define surgical principles for bowel-sparing radical treatment of ileal tumors.淋巴和血管解剖结构为保留肠管的回肠肿瘤根治性治疗确定了手术原则。
Surg Endosc. 2025 Apr;39(4):2711-2720. doi: 10.1007/s00464-025-11590-y. Epub 2025 Feb 26.
6
Novel Surgical Initiatives in Gastroenteropancreatic Neuroendocrine Tumours.胃肠胰神经内分泌肿瘤的新型手术治疗方案
Curr Oncol Rep. 2025 Feb;27(2):157-167. doi: 10.1007/s11912-024-01632-4. Epub 2025 Jan 25.
7
[Local resection of small intestine neuroendocrine neoplasms (SI-NEN) : Current principles].[小肠神经内分泌肿瘤(SI-NEN)的局部切除术:当前原则]
Chirurgie (Heidelb). 2024 Oct;95(10):818-824. doi: 10.1007/s00104-024-02102-0. Epub 2024 May 21.
8
Mesenteric sparing approach for advanced nodal extent in small intestinal neuroendocrine tumors. Is there a limit to the vascular resection in order to avoid creating a short small bowel syndrome? An anatomic research study.保留肠系膜方法治疗小肠神经内分泌肿瘤的晚期淋巴结转移。为避免发生短肠综合征,血管切除是否存在限制?一项解剖学研究。
Surg Radiol Anat. 2024 Jun;46(6):811-823. doi: 10.1007/s00276-024-03356-3. Epub 2024 Apr 23.
9
Does Telotristat Have a Role in Preventing Carcinoid Heart Disease?特罗曲塞能否预防类癌心脏病?
Int J Mol Sci. 2024 Feb 7;25(4):2036. doi: 10.3390/ijms25042036.
10
Surgery as a Principle and Technical Consideration for Primary Tumor Resection of Small Bowel Neuroendocrine Tumors.手术作为原发性小肠神经内分泌肿瘤切除的原则和技术考虑因素。
Ann Surg Oncol. 2024 Feb;31(2):1125-1137. doi: 10.1245/s10434-023-14610-0. Epub 2023 Nov 25.